Close Menu
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
What's Hot

England Ashes review: Rob Key talks about Brendon McCullum, the Harry Brook incident in Wellington and England’s lessons in Australia | Cricket News

March 23, 2026

Long lines at gas stations in China amid turmoil in the Middle East

March 23, 2026

Sam Altman-backed fusion startup Helion is in talks to sell power to OpenAI

March 23, 2026
Facebook X (Twitter) Instagram
WhistleBuzz – Smart News on AI, Business, Politics & Global Trends
Facebook X (Twitter) Instagram
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
WhistleBuzz – Smart News on AI, Business, Politics & Global Trends
Home » Stocks with the biggest price movements at noon: COIN, ANET, CVX, HAL
World

Stocks with the biggest price movements at noon: COIN, ANET, CVX, HAL

Editor-In-ChiefBy Editor-In-ChiefJanuary 5, 2026No Comments3 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email Copy Link
Follow Us
Google News Flipboard
Share
Facebook Twitter LinkedIn Pinterest Email


Check out the companies making the biggest moves this midday: Oil stocks — Shares of major U.S. oil companies soared as they are seen as beneficiaries of the country’s rebuilding of its energy infrastructure following the U.S. operation in Venezuela that led to the arrest of Venezuelan leader Nicolás Maduro. Chevron, which already has a presence there, rose 5%, and Exxon Mobil rose 2%. Oilfield services giant Halliburton soared 11%. Coinbase — The cryptocurrency exchange rose 7% after Goldman Sachs upgraded it from neutral to buy. “COIN’s scale and brand recognition continues to drive above-average revenue growth and market share expansion, and is complemented by its best-in-class (customer acquisition costs)…and recent product rollouts that increase its competitiveness across COIN, particularly in new structural growth products,” the bank wrote. Okta — The access management platform company’s stock rose about 6%. Okta announced a $1 billion stock repurchase program on Monday morning, effective immediately. Arista Networks — Shares rose more than 2% after Piper Sandler upgraded the company from neutral to overweight. “Based on our research, we believe 2026 will be a ‘year of refreshment’ that will benefit hardware vendors like Arista,” the company said. Estée Lauder — The cosmetics company rose nearly 2% on strong market performance buys on the back of Raymond James Co.’s upgrade. The company also named the company one of its top picks for 2026 as it executes a turnaround. Domino’s Pizza — The pizza chain’s stock price fell more than 3% following a downgrade by TD Cowen. Analyst Andrew Charles lowered his rating on the company from buy to hold and lowered his 2026 U.S. same-store sales forecast to 2.5% from 3%, citing headwinds from weakness in the pizza delivery segment. Phillips 66 — The oil refiner rose 7% after agreeing to buy assets and related infrastructure from Lindsay Refinery for an undisclosed sum, which will be liquidated by formal receivership. The business will be integrated into Britain’s Philips’ Humber refinery Mobileye — Self-driving car technology maker Mobileye rose more than 3% after Barclays upgraded its rating from equal weight to overweight. The bank cited a “favorable” risk/reward rationale for the rating change. QXO — The roofing and construction products distributor rose 19% after securing a $1.2 billion preferred equity investment led by private equity giant Apollo. Duolingo — The language teaching app rose 7% after Bank of America upgraded it to Buy from Neutral. “We believe (Duolingo’s) value proposition as an entertainment product is not reflected in our growth projections,” BofA said in a note. Zenas BioPharma — The Massachusetts biotech company plunged more than 50% after announcing it was no longer eligible for milestone payments with Royalty Pharma Investments under a prior agreement related to its INDIGO trial for immunoglobulin G4-related diseases. —CNBC’s Michelle Fox, Scott Schnipper, Nick Wells and Darla Mercado contributed reporting.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Editor-In-Chief
  • Website

Related Posts

Long lines at gas stations in China amid turmoil in the Middle East

March 23, 2026

More than 40 Middle East energy assets ‘severely damaged’ IEA says

March 23, 2026

India launches cheaper weight loss drugs, Novo Nordisk bets its brand will stay on top

March 23, 2026
Add A Comment

Comments are closed.

News

Iran rejects any talks with US after President Trump insists on ‘productive’ talks | US and Israel’s war on Iran News

By Editor-In-ChiefMarch 23, 2026

Iran’s parliament speaker says the US president is using the idea of ​​talks to “get…

Energy, water and bonds: What will be Iran’s target if President Trump attacks power plants? |US-Israel war against Iran News

March 23, 2026

President Trump sends ICE officers to U.S. airports amid staffing issues and delays | Donald Trump News

March 23, 2026
Top Trending

Sam Altman-backed fusion startup Helion is in talks to sell power to OpenAI

By Editor-In-ChiefMarch 23, 2026

OpenAI CEO Sam Altman is stepping down as chairman of the board…

Littlebird raises $11 million for AI-assisted ‘recall’ tool to read computer screens

By Editor-In-ChiefMarch 23, 2026

There has been a lot of discussion about building context for AI…

Startup Gimlet Labs solves AI inference bottlenecks in a surprisingly elegant way

By Editor-In-ChiefMarch 23, 2026

Zayn Asghar, an adjunct professor at Stanford University and successful founder, has…

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Welcome to WhistleBuzz.com (“we,” “our,” or “us”). Your privacy is important to us. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you visit our website https://whistlebuzz.com/ (the “Site”). Please read this policy carefully to understand our views and practices regarding your personal data and how we will treat it.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Facebook X (Twitter) Instagram Pinterest
  • Home
  • Advertise With Us
  • Contact US
  • DMCA Policy
  • Privacy Policy
  • Terms & Conditions
  • About US
© 2026 whistlebuzz. Designed by whistlebuzz.

Type above and press Enter to search. Press Esc to cancel.